Vor Biopharma Inc.
VOR
$16.10
$1.177.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -575.94% | 5,709.72% | -2,848.89% | -5,552.75% | -5.46% |
| Total Depreciation and Amortization | -96.61% | -97.34% | -99.76% | 134.41% | -12.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5,988.80% | -59,023.25% | 21,307.24% | 41,133.35% | -8.05% |
| Change in Net Operating Assets | -489.08% | 12.22% | 5,208.08% | 228.76% | 35.97% |
| Cash from Operations | -23.11% | 5.24% | -130.46% | -61.05% | -1.97% |
| Capital Expenditure | 79.22% | -336.11% | -617.65% | -1,588.89% | -102.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26,319,000.00% | -- | -- | -100.00% | -100.00% |
| Cash from Investing | -114,350.87% | -67,919.44% | -617.65% | -98.78% | -100.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 768.21% | 19,909.91% | 385.00% | -- |
| Repurchase of Common Stock | 96.36% | -393.33% | 72.86% | 37.25% | 69.78% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 76.95% | -7,432.52% | -- | -- | -- |
| Cash from Financing | 12,454.79% | 477.64% | 52,458.54% | 564,825.81% | -731.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -610.34% | 709.66% | -39.00% | 351.68% | -334.50% |